General Info

PLC Medical Systems Inc. is a worldwide leader in the development of products for performing a new surgical procedure known as transmyocardial revascularization. TMR offers a new medical treatment option for patients who suffer from severe coronary artery disease, which is a leading cause of death in the United States. More than 450,000 patients are candidates for coronary artery bypass surgery annually with approximately 80,000 patients being candidates for TMR. Working with leading researchers and premier heart surgery centers throughout the world, PLC Medical Systems developed one of the world's first Food and Drug Administration-approved TMR devices, a high-powered laser known as The Heart Laser System, which is designed to perform TMR in the safest manner possible. FDA-approved and Medicare-reimbursed, the Heart Laser System represents a new opportunity in a growing health care marketplace. PLC Medical Systems is headquartered in Franklin, Mass.